Vietnam Bio-based Polypropylene In Medical Devices Market By Application (Heart Valve Structures, Surgery sutures, Surgical Mesh, Others), By Region, Competition, Forecast and Opportunities, 2020-2030F

Market Overview

Vietnam Bio-based Polypropylene In Medical Devices Market was valued at USD 157.44 Thousand and is expected to reach USD 377.41 Thousand by 2030 with a CAGR of 15.64% during the forecast period. The Vietnam Bio-based Polypropylene in Medical Devices Market is being driven by several key factors, including increasing demand for sustainable materials, rising healthcare expenditures, and growing awareness of environmental impact. As the global healthcare industry shifts towards more eco-friendly alternatives, bio-based polypropylene (PP) is gaining popularity due to its renewable, recyclable nature and reduced environmental footprint compared to traditional polypropylene. This aligns with Vietnam’s growing emphasis on sustainability and green technologies across industries. Additionally, the medical device sector in Vietnam is expanding, fueled by rising healthcare needs, an aging population, and advancements in medical technology. Bio-based polypropylene’s superior qualities, including durability, chemical resistance, and biocompatibility, make it an ideal material for medical applications such as syringes, diagnostic devices, and packaging. The material's non-toxic nature and compliance with regulatory standards also make it an attractive choice for manufacturers seeking to meet global sustainability and quality benchmarks. These factors are collectively driving the growth of the bio-based polypropylene market in Vietnam’s medical device sector.

Key Market Drivers

Growing Demand for Sustainable Materials

The growing demand for sustainable materials is one of the primary drivers of the Vietnam Bio-based Polypropylene (Bio-PP) in Medical Devices Market. As global environmental awareness increases, the push for eco-friendly alternatives in various industries, including healthcare, becomes more prominent. The medical device sector, historically reliant on petroleum-based plastics, is under increasing pressure to adopt greener alternatives. Bio-based polypropylene, which is derived from renewable resources such as sugarcane or corn, offers a sustainable alternative to conventional polypropylene, which is made from fossil fuels. This shift towards bio-based materials not only aligns with global sustainability efforts but also responds to the demand from environmentally conscious consumers and healthcare professionals seeking products with reduced environmental footprints. In Vietnam, the growing awareness of plastic pollution, particularly in the healthcare sector, has prompted medical device manufacturers to explore bio-based options. Bio-based polypropylene is seen as a viable solution because it is biodegradable, renewable, and recyclable, addressing both environmental concerns and regulatory pressures. As the healthcare industry shifts toward more sustainable production practices, the use of bio-based polypropylene in medical devices is expected to increase significantly, catering to the demand for greener, more eco-friendly products.

Government Regulations and Incentives

Government regulations and incentives play a crucial role in driving the adoption of bio-based polypropylene in Vietnam’s medical device sector. As part of its commitment to environmental sustainability, the Vietnamese government has introduced various policies aimed at reducing plastic waste and encouraging the use of renewable materials. These policies have become more stringent, particularly in industries that rely heavily on plastics, such as the medical device sector. The government’s emphasis on sustainability is creating a favorable environment for companies to transition to bio-based materials, including bio-based polypropylene. Moreover, Vietnam’s regulatory framework is evolving to align with global standards for environmental protection, which further incentivizes manufacturers to adopt eco-friendly materials. For example, the government offers incentives like tax rebates, subsidies, and financial support to companies that adopt sustainable practices, such as using bio-based materials in their production processes. These regulations and incentives not only help companies comply with national sustainability goals but also enable them to meet international environmental standards, which are increasingly becoming a requirement for exports. As these regulations continue to evolve, the medical device sector in Vietnam is likely to see greater adoption of bio-based polypropylene, helping manufacturers achieve both compliance and competitive advantage.

Rising Healthcare Expenditures and Medical Device Demand

Vietnam’s rising healthcare expenditures and growing medical device demand are significant drivers of the bio-based polypropylene market. The country has seen a steady increase in healthcare spending due to factors such as an aging population, rising disposable incomes, and improved access to healthcare services. This growth in healthcare spending has been accompanied by a surge in the demand for medical devices, which include items like syringes, diagnostic tools, packaging, and other essential products. As the Vietnamese healthcare sector continues to expand, there is a growing need for high-quality, reliable, and eco-friendly medical products. Bio-based polypropylene is well-suited to meet this demand, offering essential properties such as strength, chemical resistance, and biocompatibility—qualities required for medical applications. Additionally, as healthcare professionals and patients alike become more health-conscious, the emphasis on using non-toxic, sustainable materials in medical devices is growing. Bio-based polypropylene is particularly valuable in the medical sector due to its durability and safety, making it an attractive material for devices that come into direct contact with pharmaceuticals or biological substances. This increased healthcare demand is, therefore, driving the market for bio-based polypropylene in Vietnam as manufacturers seek to meet both performance and environmental standards.

Increasing Awareness of Environmental Impact

Increasing awareness of the environmental impact of plastic waste is another key driver for the adoption of bio-based polypropylene in Vietnam’s medical device sector. With plastic pollution becoming a major global concern, there is heightened scrutiny on the use of plastics in all industries, including healthcare. The medical device industry has been a significant contributor to plastic waste, with products such as syringes, packaging, and medical tools often being single-use items. As awareness of the harmful effects of plastic pollution continues to grow, both consumers and manufacturers are calling for more sustainable alternatives. Bio-based polypropylene, which is derived from renewable resources and has a lower environmental footprint compared to petroleum-based plastics, provides a solution to these concerns. It is biodegradable and recyclable, helping to reduce the amount of non-recyclable plastic waste that accumulates in landfills and the environment. In Vietnam, where plastic waste management is an ongoing challenge, the medical device industry is increasingly turning to bio-based polypropylene to minimize environmental impact and align with both national and global sustainability goals. This awareness of the environmental impact of traditional plastics is a driving force behind the growing adoption of bio-based materials in medical devices.

Download Free Sample Report

Key Market Challenges

High Production Costs of Bio-based Polypropylene

One of the primary challenges in the Vietnam Bio-based Polypropylene (Bio-PP) in Medical Devices Market is the high production cost of bio-based polypropylene compared to conventional polypropylene. Despite the growing demand for sustainable and environmentally friendly materials, bio-based polypropylene still faces significant challenges in terms of cost competitiveness. The production of bio-based polypropylene typically involves more complex processes than traditional polypropylene, including the extraction and fermentation of renewable resources such as corn or sugarcane. These processes are often more resource-intensive and can result in higher production costs.

In addition, bio-based polypropylene is produced on a smaller scale compared to its petroleum-based counterpart, which further drives up the cost. The economies of scale that benefit traditional polypropylene production are not as accessible to bio-based manufacturers, making it difficult for producers to lower the unit price of bio-based materials. This higher production cost is often passed on to consumers, making bio-based polypropylene more expensive for manufacturers who are seeking to incorporate it into medical devices. Given the price sensitivity of many healthcare product buyers, the higher cost of bio-based polypropylene may deter manufacturers from adopting this material on a large scale, especially if cheaper alternatives remain available.

This price challenge is compounded by the fact that bio-based polypropylene is still evolving in terms of production technology and efficiency. Although advancements are being made to improve the cost-effectiveness of bio-based polypropylene, the production methods are still under development and can vary greatly depending on the production plant and regional factors. This variation leads to price volatility and makes it difficult for companies to consistently rely on bio-based polypropylene as a stable, cost-effective material. Furthermore, the supply of renewable raw materials such as sugarcane or corn can fluctuate due to factors such as climate change or crop shortages, which can further increase the cost of production.

Despite these challenges, many companies in Vietnam are still exploring ways to overcome these barriers by investing in more efficient production technologies, securing long-term supply agreements for raw materials, and increasing their commitment to sustainability. However, for the widespread adoption of bio-based polypropylene in medical devices, the issue of high production costs needs to be addressed. If not, manufacturers may continue to opt for cheaper, petroleum-based polypropylene, which could slow down the overall growth of the market for bio-based materials.

Limited Availability and Scalability of Bio-based Polypropylene

Another significant challenge faced by the Vietnam Bio-based Polypropylene in Medical Devices Market is the limited availability and scalability of bio-based polypropylene. While bio-based polypropylene has been increasingly recognized as a sustainable and viable alternative to conventional plastics, its availability remains relatively limited, especially in developing markets like Vietnam. This is largely due to the fact that bio-based polypropylene production is still in the nascent stages when compared to the well-established infrastructure for petroleum-based polypropylene.

The supply chain for bio-based polypropylene is not as mature as that of traditional polypropylene, which creates bottlenecks in its availability. As demand for bio-based polypropylene rises globally, many manufacturers find themselves competing for access to limited resources, such as renewable feedstocks (corn, sugarcane, etc.) and production capacity. Moreover, the infrastructure required for the large-scale production of bio-based polypropylene is not yet widespread, and many manufacturers lack access to the specialized technology needed to produce high-quality bio-based polypropylene at scale.

For the market to grow, Vietnam needs to see an increase in both the production capacity for bio-based polypropylene and the number of suppliers. However, scaling up production requires substantial investment in infrastructure, research and development, and raw material sourcing. While some global manufacturers have begun to invest in expanding their bio-based polypropylene production facilities, such investments are capital-intensive and may take years to materialize. Consequently, the limited availability of bio-based polypropylene continues to be a key challenge for manufacturers in Vietnam, who may be hesitant to fully transition to bio-based materials without reliable, large-scale access to these materials. In addition, the feedstocks used to produce bio-based polypropylene are subject to fluctuations in agricultural supply chains, which can be influenced by factors such as droughts, price volatility, and changing demand for food crops. This volatility can disrupt the production of bio-based polypropylene and make it difficult for manufacturers in Vietnam to secure a consistent supply of these materials. Until the supply chain for bio-based polypropylene becomes more robust and scalable, limited availability will continue to be a significant barrier to the widespread adoption of bio-based polypropylene in medical devices.

Key Market Trends

Technological Advancements in Bio-based Materials

Advancements in the production and processing of bio-based materials have made bio-based polypropylene increasingly competitive with conventional polypropylene. In December 2021, South Korean chemicals company Hyosung Vina Chemicals has invested USD 1.3 billion to build a polypropylene (PP) plant and a liquefied petroleum gas (LPG) storage cavern at the Cai Mep Industrial Park in Ba Ria-Vung Tau province, Vietnam. The project was approved by Vietnam's Prime Minister in 2018, with construction of the plant beginning that same year. Once fully operational, the plant will produce 650,000 tonnes of PP annually, with 300,000 tonnes earmarked for the domestic Vietnamese market. The PP produced will be used in the manufacturing of various products, including textiles, in Vietnam.

Over the years, significant technological progress has been made in improving the quality, performance, and affordability of bio-based polypropylene. Innovations in biopolymer production techniques and polymer processing technologies have improved the efficiency of bio-based polypropylene manufacturing, making it a more cost-effective option for medical device producers. As a result, the price difference between bio-based and traditional polypropylene has narrowed, making bio-based polypropylene a more accessible material for companies looking to meet both performance and sustainability goals. These technological advancements have also enhanced the material’s consistency, ensuring that it meets the stringent quality and safety standards required for medical devices. With these innovations, bio-based polypropylene is becoming a more attractive choice for manufacturers who are looking to adopt sustainable materials without compromising on performance. As technology continues to improve, it is likely that the bio-based polypropylene market will grow, supported by continued reductions in production costs and improvements in material performance.

Global Trends Towards Sustainable Healthcare Products

There is a clear global trend towards the use of sustainable materials in healthcare products, and this trend is influencing markets worldwide, including Vietnam. In many regions, international healthcare organizations and regulatory bodies are introducing sustainability standards for medical devices, which include requirements for the use of eco-friendly materials. In July 2022, A private Vietnamese petrochemical company plans to invest USD 1.5 billion in a polypropylene plant located in the northern province of Quang Ninh. Stavian Quang Yen Petrochemical JSC is set to begin commercial operations at the plant in the fourth quarter of 2026, with an expected annual production capacity of 600,000 tonnes of polypropylene.

As global demand for greener healthcare products rises, medical device manufacturers in Vietnam are increasingly seeking to align with these international trends to remain competitive in the global market. Bio-based polypropylene is an attractive option for manufacturers aiming to meet international sustainability standards while ensuring that their products perform reliably in medical applications. This trend is particularly important for Vietnam, which is positioning itself as a growing hub for medical device manufacturing, and is looking to expand its export market. Adopting bio-based materials helps manufacturers in Vietnam meet both local and international demand for sustainable products and ensures compliance with increasingly stringent regulations regarding environmental impact. As the global push for sustainability in healthcare continues to grow, the adoption of bio-based polypropylene in Vietnam is expected to increase, providing a competitive edge to manufacturers in the market.

Segmental Insights

Application Insights

Based on the Application, surgical sutures are currently dominating the market. Surgical sutures, which are used to close wounds or surgical incisions, are a vital part of modern healthcare, and the demand for them has been steadily rising due to increasing surgical procedures, advancements in healthcare infrastructure, and a growing population in need of medical interventions. These sutures are typically made from various materials, including natural and synthetic polymers, with polypropylene being one of the most common choices. The transition to bio-based polypropylene for surgical sutures is gaining momentum as healthcare professionals and manufacturers seek more sustainable, eco-friendly alternatives to traditional petroleum-based plastics.

Bio-based polypropylene offers significant advantages over conventional polypropylene in the production of surgical sutures, primarily in its reduced environmental impact. As sustainability becomes increasingly important in healthcare and consumer choices, bio-based alternatives are highly attractive because they are derived from renewable resources, such as sugarcane or corn, rather than fossil fuels. Additionally, bio-based polypropylene provides excellent strength, durability, and biocompatibility, making it an ideal material for use in sutures that need to perform reliably in the human body.

Download Free Sample Report

Regional Insights

In the Vietnam Bio-based Polypropylene in Medical Devices Market, Southern Vietnam is currently the dominant region. The Southern region, particularly cities like Ho Chi Minh City, plays a central role in the country’s medical device manufacturing and distribution. Ho Chi Minh City is not only the economic hub of Vietnam but also home to a high concentration of manufacturing facilities, including those producing medical devices. As Vietnam’s medical device industry continues to expand, Southern Vietnam has become the focal point for the adoption of bio-based polypropylene in medical products.

Several factors contribute to the dominance of Southern Vietnam in this market. First, the region’s advanced industrial infrastructure and established medical manufacturing ecosystem provide a solid foundation for the widespread adoption of innovative materials like bio-based polypropylene. Many global and local medical device manufacturers have established their production plants in this area, creating a competitive environment for the incorporation of sustainable materials. Additionally, Southern Vietnam’s proximity to major ports like Cat Lai Port enables easy access to raw materials and finished medical products, facilitating the distribution of bio-based polypropylene materials for medical device production. Furthermore, Southern Vietnam benefits from its developed research and development (R&D) facilities, which support the advancement of medical device technologies, including the integration of eco-friendly materials like bio-based polypropylene. With an increasing focus on sustainability within the medical sector, manufacturers in the south are increasingly exploring bio-based polypropylene as an alternative to petroleum-based plastics, especially for critical products like surgical sutures, medical packaging, and diagnostic equipment.

Recent Developments

• In August 2024, Vietnam's Long Son is set to launch its polyolefins plants this week, following the restart of its mixed-feed cracker last week, which has a production capacity of up to 950,000 tons per year of ethylene and 400,000 tons per year of propylene. The company has already begun operations at its new 500,000 tons per year high-density polyethylene (HDPE) plant and 400,000 tons per year polypropylene (PP) plant earlier this week. Sources close to the company indicate that both plants are expected to produce products that meet specifications. Additionally, its new 500,000 tons per year linear low-density polyethylene (LLDPE) plant is anticipated to begin operations within the week.
• In December 2023, South Korean consumer goods company Aekyung Chemical announced that it has acquired VPCHEM, the Vietnam subsidiary of LG Chem Ltd., which is involved in the production and sale of plasticizers. Aekyung Chemical has acquired the 50% stake in VPCHEM that was previously held by LG Chem.
• In April 2024, Hyosung TNC (Seoul, South Korea) recently obtained investment approval for the "Hyosung BDO Project" in southern Vietnam. The company plans to strategically address the global materials market's shift towards sustainable products by investing in the establishment of multiple Bio-BDO production plants.
• In May 2024, South Korean conglomerate SK Group has begun construction of a bioplastics plant in Haiphong, a city in northeastern Vietnam. The plant is expected to be completed by June 2025, with operations slated to begin three months thereafter. Once fully operational, the facility will produce 70,000 tonnes per year of polybutylene adipate terephthalate (PBAT), 59,500 tonnes per year of polybutylene succinate (PBS), and 6,300 tonnes per year of tetrahydrofuran (THF) solvent products.

Key Market Players

• SABIC Vietnam Co. Ltd.
• LyondellBasell Vietnam Company Limited
• Mitsui & Co. (Asia Pacific) Pte. Ltd.
• Avient Vietnam Co., Ltd.
• Tan Dai Hung Plastic J.S Co.
• Cpi Viet Nam Plastic Limited Company

Report Scope:

In this report, the Vietnam Bio-based Polypropylene In Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·       Vietnam Bio-based Polypropylene In Medical Devices Market, By Application:

o   Heart Valve Structures

o   Surgery sutures

o   Surgical Mesh

o   Others

•         Vietnam Bio-based Polypropylene In Medical Devices Market, By Region:

o   Southern Vietnam

o   Northern Vietnam

o   Central Vietnam

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Vietnam Bio-based Polypropylene In Medical Devices Market.

Available Customizations:

Vietnam Bio-based Polypropylene In Medical Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Vietnam Bio-based Polypropylene In Medical Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]